hemophilianewstoday.com /1 month ago

Blood tests may vary in measuring factor VIII after treatment

Blood tests can give different readings of factor VIII (FVIII) activity after treatment with Altuvoct (efanesoctocog alfa), marketed as Altuviiio in the U.S., a study found. The di...

Read source
hemophilianewstoday.com /1 month ago

Persistent bleeding after dental work may signal mild hemophilia

Bleeding that persists or restarts after dental procedures may be an important warning sign of previously undiagnosed mild hemophilia, a systematic review of published case reports...

Read source
bioengineer.org /1 week ago

Blood Biomarkers Distinguish Young Adults at Risk of Post-Traumatic Knee Osteoarthritis

Circulating extracellular matrix protein fragments are elevated in young adults one to seven years after surgically managed knee injury compared to matched controls.

Read source
hemophilianewstoday.com /1 month ago

AI shows early promise for hemophilia diagnosis, care

Artificial intelligence (AI) shows promise for helping doctors diagnose hemophilia, detect joint complications, and predict disease severity and other clinical outcomes, a review o...

Read source
hemophilianewstoday.com /1 month ago

Study finds progress, gaps in hemophilia B diagnosis and care

More people are being identified with hemophilia B across the eastern Mediterranean region, suggesting improvements in hemophilia diagnosis and reporting, according to a study anal...

Read source
hemophilianewstoday.com /2 weeks ago

Weekly infusion reduces bleeding in boys with hemophilia A

Once-weekly preventive treatment with Altuviiio (efanesoctocog alfa) safely reduced bleeding rates while maintaining protective clotting factor levels without triggering neutralizi...

Read source
hemophilianewstoday.com /3 weeks ago

Liver enzyme elevations may recur after hemophilia B gene therapy

Liver enzyme levels may rise again as corticosteroid doses are gradually reduced in people with hemophilia B treated with Hemgenix, a case report suggests. Elevated liver enzymes a...

Read source
hemophilianewstoday.com /2 days ago

Preventive treatment curbs bleeding in mild, moderate hemophilia A

Preventive treatment with Hemlibra (emicizumab-kxwh) kept bleeding under control for nearly three years in people with mild or moderate hemophilia A without inhibitors. That’s acco...

Read source
bioengineer.org /1 month ago

Clinical severity outperforms routine biomarkers for predicting stroke bleeding

A temporal-validation study of 847 stroke patients found that clinical severity and established risk factors predicted hemorrhagic transformation more reliably than routine inflamm...

Read source
hemophilianewstoday.com /1 month ago

Low-dose treatment cuts bleeds in kids with hemophilia A

Preventive treatment with low-dose Hemlibra (emicizumab-KXWH) significantly reduced bleeding and improved quality of life in young children with hemophilia A, regardless of inhibit...

Read source
hemophilianewstoday.com /1 month ago

Oral hemophilia A treatment shows promise in preclinical studies

Inno8, a potential oral treatment to prevent bleeds in people with hemophilia A, appears more potent and long-lasting than currently available injectable treatments in preclinical...

Read source
bioengineer.org /4 weeks ago

Blood Proteins Predict ALS Years Before Symptoms Strike

A large prospective UK Biobank study of 52,584 adults identified nine plasma proteins, led by neurofilament light chain, that predict ALS onset up to a decade before symptoms, with...

Read source
hemophilianewstoday.com /2 weeks ago

Hemophilia carriers face changing worries across generations, study finds

A small study in Japan suggests that younger women identified as hemophilia carriers have greater access to information and specialized care than women in an earlier generation, bu...

Read source
hemophilianewstoday.com /3 weeks ago

Doctors offer tips to improve care for women, girls with hemophilia

By educating and empowering patients and their families, clinicians can help improve access to accurate diagnoses and care for women and girls affected by hemophilia. That’s the ar...

Read source
hemophilianewstoday.com /5 days ago

New injection therapy for hemophilia A, Frehemgo, wins approval in Europe

The injection therapy denecimig for hemophilia A — designed to prevent bleeding episodes in adults and children with or without inhibitors — has been approved in the European Union...

Read source
hemophilianewstoday.com /4 weeks ago

My grandmother had a bleeding story. I had a hemophilia diagnosis.

Every new hematologist asks the same question: “Who else in your family has it?” For most of my life, the answer was nobody. Nobody with a diagnosis, anyway. I was diagnosed with h...

Read source
hemophilianewstoday.com /1 week ago

FDA clears clinical trial of gene-editing therapy for hemophilia A

The U.S. Food and Drug Administration (FDA) has given the go-ahead for Metagenomi Therapeutics to start a first-in-human clinical trial testing MGX-001, the company’s experimental...

Read source
journals.plos.org /6 days ago

Proteogenomic analysis of 5,411 plasma proteins in sickle cell disease patients

by Cristian Groza, Arnaud Chignon, Ken Sin Lo, Vanessa Bellegarde, Pablo Bartolucci, Guillaume Lettre There are few therapeutic options to treat patients with sickle cell disease...

Read source
bioengineer.org /1 month ago

Simple Blood Ratio HRR Emerges as a New Clue for Detecting Diabetic Kidney Disease

A large MIMIC-IV study finds that a low hemoglobin-to-red cell distribution width ratio is associated with diabetic kidney disease in critically ill patients with type 2 diabetes.

Read source
hemophilianewstoday.com /1 month ago

Hemophilia A drives healthcare costs higher, says study in Canada

Hemophilia A patients rack up high hospital bills, driving costs for the healthcare system higher, a study from Canada showed. “This study confirms that even with improved [treatme...

Read source
oxfordmail.co.uk /6 days ago

Oxford experts secure £520k for new haemophilia treatment trial

The study, led by two specialists from Oxford University Hospitals (OUH), will explore whether a naturally occurring joint fluid could reduce pain.

Read source
biopharmadive.com /1 week ago

Bayer wins FDA nod for a new kind of blood thinner

Sunharbo’s U.S. approval is the first for a “Factor XIa” inhibitor, an anticipated class of medicines seen as a possible step forward in stroke prevention. 

Read source
nephronpower.com /1 month ago

Topic Discussion: Galactose deficient(Gd)-IgA1 as a biomarker in IgA nephropathy after the recent RCTs

The recent wave of IgAN trials has reinforced galactose-deficient IgA1 (Gd-IgA1) as a mechanistic/pharmacodynamic biomarker, but not as a validated diagnostic or monitoring test. A...

Read source
hemophilianewstoday.com /1 month ago

More than half with hemophilia had gaps in prescribed factor treatment

More than half of people with hemophilia receiving prophylactic (preventive) factor replacement therapies at two treatment centers in Brazil did not collect enough medication to fo...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.